nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—SLCO1A2—Prednisolone—multiple sclerosis	0.0649	0.0969	CbGbCtD
Lovastatin—SLCO1A2—Prednisone—multiple sclerosis	0.0612	0.0915	CbGbCtD
Lovastatin—CYP2D6—Fingolimod—multiple sclerosis	0.0399	0.0597	CbGbCtD
Lovastatin—SLCO1A2—Dexamethasone—multiple sclerosis	0.0382	0.0571	CbGbCtD
Lovastatin—ABCC2—Dexamethasone—multiple sclerosis	0.0317	0.0473	CbGbCtD
Lovastatin—SLCO1A2—Methotrexate—multiple sclerosis	0.0307	0.0459	CbGbCtD
Lovastatin—SLCO1B1—Methotrexate—multiple sclerosis	0.029	0.0433	CbGbCtD
Lovastatin—ABCB1—Methylprednisolone—multiple sclerosis	0.0273	0.0408	CbGbCtD
Lovastatin—ABCC2—Methotrexate—multiple sclerosis	0.0255	0.0381	CbGbCtD
Lovastatin—CYP3A4—Fingolimod—multiple sclerosis	0.0254	0.0379	CbGbCtD
Lovastatin—CYP3A7—Dexamethasone—multiple sclerosis	0.0212	0.0316	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0212	0.0316	CbGbCtD
Lovastatin—CYP2C19—Prednisone—multiple sclerosis	0.0205	0.0306	CbGbCtD
Lovastatin—ABCB1—Mitoxantrone—multiple sclerosis	0.0199	0.0298	CbGbCtD
Lovastatin—ABCB1—Betamethasone—multiple sclerosis	0.0178	0.0265	CbGbCtD
Lovastatin—ABCB1—Prednisolone—multiple sclerosis	0.0175	0.0262	CbGbCtD
Lovastatin—ABCB1—Prednisone—multiple sclerosis	0.0166	0.0247	CbGbCtD
Lovastatin—CYP3A4—Methylprednisolone—multiple sclerosis	0.0164	0.0245	CbGbCtD
Lovastatin—CYP3A5—Dexamethasone—multiple sclerosis	0.0159	0.0237	CbGbCtD
Lovastatin—CYP2C8—Dexamethasone—multiple sclerosis	0.0153	0.0228	CbGbCtD
Lovastatin—CYP2C19—Dexamethasone—multiple sclerosis	0.0128	0.0191	CbGbCtD
Lovastatin—CYP3A4—Triamcinolone—multiple sclerosis	0.0124	0.0185	CbGbCtD
Lovastatin—CYP3A4—Mitoxantrone—multiple sclerosis	0.0119	0.0178	CbGbCtD
Lovastatin—CYP2C9—Dexamethasone—multiple sclerosis	0.0106	0.0159	CbGbCtD
Lovastatin—CYP3A4—Betamethasone—multiple sclerosis	0.0106	0.0159	CbGbCtD
Lovastatin—CYP3A4—Prednisolone—multiple sclerosis	0.0105	0.0157	CbGbCtD
Lovastatin—ABCB1—Dexamethasone—multiple sclerosis	0.0103	0.0154	CbGbCtD
Lovastatin—CYP3A4—Prednisone—multiple sclerosis	0.00992	0.0148	CbGbCtD
Lovastatin—CYP2D6—Dexamethasone—multiple sclerosis	0.00974	0.0145	CbGbCtD
Lovastatin—ABCB1—Methotrexate—multiple sclerosis	0.0083	0.0124	CbGbCtD
Lovastatin—CYP3A4—Dexamethasone—multiple sclerosis	0.00619	0.00925	CbGbCtD
Lovastatin—ITGAL—medulla oblongata—multiple sclerosis	0.00147	0.0786	CbGeAlD
Lovastatin—ITGAL—midbrain—multiple sclerosis	0.00134	0.0718	CbGeAlD
Lovastatin—ITGAL—spinal cord—multiple sclerosis	0.00131	0.0701	CbGeAlD
Lovastatin—ITGAL—cerebellum—multiple sclerosis	0.00104	0.0556	CbGeAlD
Lovastatin—ITGAL—brain—multiple sclerosis	0.000845	0.0451	CbGeAlD
Lovastatin—HDAC2—brainstem—multiple sclerosis	0.000843	0.045	CbGeAlD
Lovastatin—PON3—brain—multiple sclerosis	0.000829	0.0443	CbGeAlD
Lovastatin—HDAC2—retina—multiple sclerosis	0.000814	0.0435	CbGeAlD
Lovastatin—HDAC2—medulla oblongata—multiple sclerosis	0.000588	0.0314	CbGeAlD
Lovastatin—HDAC2—midbrain—multiple sclerosis	0.000537	0.0287	CbGeAlD
Lovastatin—HMGCR—medulla oblongata—multiple sclerosis	0.000531	0.0283	CbGeAlD
Lovastatin—HMGCR—midbrain—multiple sclerosis	0.000485	0.0259	CbGeAlD
Lovastatin—HMGCR—spinal cord—multiple sclerosis	0.000473	0.0253	CbGeAlD
Lovastatin—HDAC2—nervous system—multiple sclerosis	0.000442	0.0236	CbGeAlD
Lovastatin—HDAC2—central nervous system—multiple sclerosis	0.000425	0.0227	CbGeAlD
Lovastatin—HDAC2—cerebellum—multiple sclerosis	0.000416	0.0222	CbGeAlD
Lovastatin—SLCO1A2—medulla oblongata—multiple sclerosis	0.000414	0.0221	CbGeAlD
Lovastatin—HMGCR—nervous system—multiple sclerosis	0.000399	0.0213	CbGeAlD
Lovastatin—HMGCR—central nervous system—multiple sclerosis	0.000384	0.0205	CbGeAlD
Lovastatin—SLCO1A2—midbrain—multiple sclerosis	0.000378	0.0202	CbGeAlD
Lovastatin—HMGCR—cerebellum—multiple sclerosis	0.000375	0.02	CbGeAlD
Lovastatin—SLCO1A2—spinal cord—multiple sclerosis	0.000369	0.0197	CbGeAlD
Lovastatin—HDAC2—brain—multiple sclerosis	0.000338	0.018	CbGeAlD
Lovastatin—SLCO1A2—nervous system—multiple sclerosis	0.000311	0.0166	CbGeAlD
Lovastatin—HMGCR—brain—multiple sclerosis	0.000305	0.0163	CbGeAlD
Lovastatin—SLCO1A2—central nervous system—multiple sclerosis	0.000299	0.016	CbGeAlD
Lovastatin—SLCO1A2—cerebellum—multiple sclerosis	0.000292	0.0156	CbGeAlD
Lovastatin—CYP2D6—brainstem—multiple sclerosis	0.000276	0.0148	CbGeAlD
Lovastatin—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000271	0.00176	CcSEcCtD
Lovastatin—Back pain—Triamcinolone—multiple sclerosis	0.00027	0.00176	CcSEcCtD
Lovastatin—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000269	0.00175	CcSEcCtD
Lovastatin—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000266	0.00173	CcSEcCtD
Lovastatin—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000263	0.00171	CcSEcCtD
Lovastatin—Eosinophilia—Methotrexate—multiple sclerosis	0.000262	0.0017	CcSEcCtD
Lovastatin—Fatigue—Mitoxantrone—multiple sclerosis	0.000261	0.00169	CcSEcCtD
Lovastatin—Pancreatitis—Methotrexate—multiple sclerosis	0.00026	0.00169	CcSEcCtD
Lovastatin—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000259	0.00168	CcSEcCtD
Lovastatin—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000259	0.00168	CcSEcCtD
Lovastatin—Pain—Mitoxantrone—multiple sclerosis	0.000258	0.00168	CcSEcCtD
Lovastatin—Constipation—Mitoxantrone—multiple sclerosis	0.000258	0.00168	CcSEcCtD
Lovastatin—Alopecia—Betamethasone—multiple sclerosis	0.000257	0.00167	CcSEcCtD
Lovastatin—Alopecia—Dexamethasone—multiple sclerosis	0.000257	0.00167	CcSEcCtD
Lovastatin—Diarrhoea—Azathioprine—multiple sclerosis	0.000256	0.00166	CcSEcCtD
Lovastatin—Discomfort—Prednisolone—multiple sclerosis	0.000256	0.00166	CcSEcCtD
Lovastatin—Angioedema—Triamcinolone—multiple sclerosis	0.000255	0.00166	CcSEcCtD
Lovastatin—Angioedema—Methylprednisolone—multiple sclerosis	0.000255	0.00165	CcSEcCtD
Lovastatin—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000254	0.00165	CcSEcCtD
Lovastatin—Malaise—Triamcinolone—multiple sclerosis	0.000252	0.00164	CcSEcCtD
Lovastatin—Malaise—Methylprednisolone—multiple sclerosis	0.000251	0.00163	CcSEcCtD
Lovastatin—Vertigo—Triamcinolone—multiple sclerosis	0.000251	0.00163	CcSEcCtD
Lovastatin—Vertigo—Methylprednisolone—multiple sclerosis	0.00025	0.00163	CcSEcCtD
Lovastatin—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000249	0.00162	CcSEcCtD
Lovastatin—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000248	0.00161	CcSEcCtD
Lovastatin—Dizziness—Azathioprine—multiple sclerosis	0.000247	0.00161	CcSEcCtD
Lovastatin—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000247	0.00161	CcSEcCtD
Lovastatin—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000244	0.00158	CcSEcCtD
Lovastatin—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000242	0.00157	CcSEcCtD
Lovastatin—Urticaria—Mitoxantrone—multiple sclerosis	0.00024	0.00156	CcSEcCtD
Lovastatin—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000239	0.00155	CcSEcCtD
Lovastatin—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000239	0.00155	CcSEcCtD
Lovastatin—Myalgia—Triamcinolone—multiple sclerosis	0.000238	0.00155	CcSEcCtD
Lovastatin—Vomiting—Azathioprine—multiple sclerosis	0.000238	0.00154	CcSEcCtD
Lovastatin—SLCO1A2—brain—multiple sclerosis	0.000238	0.0127	CbGeAlD
Lovastatin—Arthralgia—Methylprednisolone—multiple sclerosis	0.000237	0.00154	CcSEcCtD
Lovastatin—Myalgia—Methylprednisolone—multiple sclerosis	0.000237	0.00154	CcSEcCtD
Lovastatin—Anxiety—Methylprednisolone—multiple sclerosis	0.000237	0.00154	CcSEcCtD
Lovastatin—Rash—Azathioprine—multiple sclerosis	0.000236	0.00153	CcSEcCtD
Lovastatin—Dermatitis—Azathioprine—multiple sclerosis	0.000236	0.00153	CcSEcCtD
Lovastatin—Flushing—Prednisone—multiple sclerosis	0.000235	0.00153	CcSEcCtD
Lovastatin—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000235	0.00153	CcSEcCtD
Lovastatin—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000235	0.00153	CcSEcCtD
Lovastatin—Discomfort—Triamcinolone—multiple sclerosis	0.000235	0.00153	CcSEcCtD
Lovastatin—Discomfort—Methylprednisolone—multiple sclerosis	0.000234	0.00152	CcSEcCtD
Lovastatin—Headache—Azathioprine—multiple sclerosis	0.000234	0.00152	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000234	0.00152	CcSEcCtD
Lovastatin—Dry mouth—Triamcinolone—multiple sclerosis	0.000233	0.00151	CcSEcCtD
Lovastatin—Angioedema—Dexamethasone—multiple sclerosis	0.000232	0.0015	CcSEcCtD
Lovastatin—Angioedema—Betamethasone—multiple sclerosis	0.000232	0.0015	CcSEcCtD
Lovastatin—Confusional state—Methylprednisolone—multiple sclerosis	0.000229	0.00149	CcSEcCtD
Lovastatin—Malaise—Dexamethasone—multiple sclerosis	0.000229	0.00148	CcSEcCtD
Lovastatin—Malaise—Betamethasone—multiple sclerosis	0.000229	0.00148	CcSEcCtD
Lovastatin—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000228	0.00148	CcSEcCtD
Lovastatin—Vertigo—Dexamethasone—multiple sclerosis	0.000228	0.00148	CcSEcCtD
Lovastatin—Vertigo—Betamethasone—multiple sclerosis	0.000228	0.00148	CcSEcCtD
Lovastatin—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000228	0.00148	CcSEcCtD
Lovastatin—Infection—Triamcinolone—multiple sclerosis	0.000227	0.00147	CcSEcCtD
Lovastatin—Infection—Methylprednisolone—multiple sclerosis	0.000226	0.00147	CcSEcCtD
Lovastatin—Insomnia—Prednisolone—multiple sclerosis	0.000224	0.00146	CcSEcCtD
Lovastatin—Alopecia—Prednisone—multiple sclerosis	0.000224	0.00146	CcSEcCtD
Lovastatin—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000223	0.00145	CcSEcCtD
Lovastatin—Paraesthesia—Prednisolone—multiple sclerosis	0.000223	0.00145	CcSEcCtD
Lovastatin—Nausea—Azathioprine—multiple sclerosis	0.000222	0.00144	CcSEcCtD
Lovastatin—Asthenia—Mitoxantrone—multiple sclerosis	0.000217	0.00141	CcSEcCtD
Lovastatin—Myalgia—Betamethasone—multiple sclerosis	0.000216	0.0014	CcSEcCtD
Lovastatin—Myalgia—Dexamethasone—multiple sclerosis	0.000216	0.0014	CcSEcCtD
Lovastatin—Anxiety—Betamethasone—multiple sclerosis	0.000215	0.0014	CcSEcCtD
Lovastatin—Anxiety—Dexamethasone—multiple sclerosis	0.000215	0.0014	CcSEcCtD
Lovastatin—Discomfort—Betamethasone—multiple sclerosis	0.000213	0.00139	CcSEcCtD
Lovastatin—Discomfort—Dexamethasone—multiple sclerosis	0.000213	0.00139	CcSEcCtD
Lovastatin—Pain—Prednisolone—multiple sclerosis	0.000212	0.00138	CcSEcCtD
Lovastatin—Hepatitis—Methotrexate—multiple sclerosis	0.000212	0.00138	CcSEcCtD
Lovastatin—Vision blurred—Prednisone—multiple sclerosis	0.000208	0.00135	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000208	0.00135	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000207	0.00135	CcSEcCtD
Lovastatin—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000207	0.00134	CcSEcCtD
Lovastatin—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000207	0.00134	CcSEcCtD
Lovastatin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000207	0.00134	CcSEcCtD
Lovastatin—Insomnia—Triamcinolone—multiple sclerosis	0.000206	0.00134	CcSEcCtD
Lovastatin—Insomnia—Methylprednisolone—multiple sclerosis	0.000206	0.00134	CcSEcCtD
Lovastatin—Infection—Betamethasone—multiple sclerosis	0.000206	0.00134	CcSEcCtD
Lovastatin—Infection—Dexamethasone—multiple sclerosis	0.000206	0.00134	CcSEcCtD
Lovastatin—Ill-defined disorder—Prednisone—multiple sclerosis	0.000205	0.00133	CcSEcCtD
Lovastatin—Paraesthesia—Triamcinolone—multiple sclerosis	0.000205	0.00133	CcSEcCtD
Lovastatin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000204	0.00133	CcSEcCtD
Lovastatin—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000204	0.00133	CcSEcCtD
Lovastatin—Dyspnoea—Triamcinolone—multiple sclerosis	0.000203	0.00132	CcSEcCtD
Lovastatin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000203	0.00132	CcSEcCtD
Lovastatin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000203	0.00132	CcSEcCtD
Lovastatin—Angioedema—Prednisone—multiple sclerosis	0.000202	0.00131	CcSEcCtD
Lovastatin—Dyspepsia—Triamcinolone—multiple sclerosis	0.000201	0.0013	CcSEcCtD
Lovastatin—Erythema multiforme—Methotrexate—multiple sclerosis	0.0002	0.0013	CcSEcCtD
Lovastatin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.0002	0.0013	CcSEcCtD
Lovastatin—Malaise—Prednisone—multiple sclerosis	0.000199	0.00129	CcSEcCtD
Lovastatin—Vertigo—Prednisone—multiple sclerosis	0.000198	0.00129	CcSEcCtD
Lovastatin—Anorexia—Betamethasone—multiple sclerosis	0.000197	0.00128	CcSEcCtD
Lovastatin—Anorexia—Dexamethasone—multiple sclerosis	0.000197	0.00128	CcSEcCtD
Lovastatin—Urticaria—Prednisolone—multiple sclerosis	0.000197	0.00128	CcSEcCtD
Lovastatin—Fatigue—Triamcinolone—multiple sclerosis	0.000197	0.00128	CcSEcCtD
Lovastatin—Fatigue—Methylprednisolone—multiple sclerosis	0.000196	0.00127	CcSEcCtD
Lovastatin—Pain—Triamcinolone—multiple sclerosis	0.000195	0.00127	CcSEcCtD
Lovastatin—Vomiting—Mitoxantrone—multiple sclerosis	0.000192	0.00125	CcSEcCtD
Lovastatin—ABCB1—retina—multiple sclerosis	0.000192	0.0102	CbGeAlD
Lovastatin—Rash—Mitoxantrone—multiple sclerosis	0.000191	0.00124	CcSEcCtD
Lovastatin—Dermatitis—Mitoxantrone—multiple sclerosis	0.00019	0.00124	CcSEcCtD
Lovastatin—Chills—Methotrexate—multiple sclerosis	0.00019	0.00124	CcSEcCtD
Lovastatin—Headache—Mitoxantrone—multiple sclerosis	0.000189	0.00123	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000188	0.00122	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000188	0.00122	CcSEcCtD
Lovastatin—Arthralgia—Prednisone—multiple sclerosis	0.000188	0.00122	CcSEcCtD
Lovastatin—Myalgia—Prednisone—multiple sclerosis	0.000188	0.00122	CcSEcCtD
Lovastatin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000188	0.00122	CcSEcCtD
Lovastatin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000187	0.00122	CcSEcCtD
Lovastatin—Anxiety—Prednisone—multiple sclerosis	0.000187	0.00122	CcSEcCtD
Lovastatin—Alopecia—Methotrexate—multiple sclerosis	0.000187	0.00122	CcSEcCtD
Lovastatin—Insomnia—Dexamethasone—multiple sclerosis	0.000187	0.00122	CcSEcCtD
Lovastatin—Insomnia—Betamethasone—multiple sclerosis	0.000187	0.00122	CcSEcCtD
Lovastatin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000186	0.00121	CcSEcCtD
Lovastatin—Paraesthesia—Betamethasone—multiple sclerosis	0.000186	0.00121	CcSEcCtD
Lovastatin—Paraesthesia—Dexamethasone—multiple sclerosis	0.000186	0.00121	CcSEcCtD
Lovastatin—Discomfort—Prednisone—multiple sclerosis	0.000186	0.00121	CcSEcCtD
Lovastatin—Hypersensitivity—Prednisolone—multiple sclerosis	0.000183	0.00119	CcSEcCtD
Lovastatin—Dyspepsia—Betamethasone—multiple sclerosis	0.000182	0.00118	CcSEcCtD
Lovastatin—Dyspepsia—Dexamethasone—multiple sclerosis	0.000182	0.00118	CcSEcCtD
Lovastatin—Urticaria—Triamcinolone—multiple sclerosis	0.000181	0.00118	CcSEcCtD
Lovastatin—Urticaria—Methylprednisolone—multiple sclerosis	0.000181	0.00117	CcSEcCtD
Lovastatin—Dysgeusia—Methotrexate—multiple sclerosis	0.000181	0.00117	CcSEcCtD
Lovastatin—Body temperature increased—Triamcinolone—multiple sclerosis	0.00018	0.00117	CcSEcCtD
Lovastatin—Anaphylactic shock—Prednisone—multiple sclerosis	0.00018	0.00117	CcSEcCtD
Lovastatin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00018	0.00117	CcSEcCtD
Lovastatin—Decreased appetite—Betamethasone—multiple sclerosis	0.00018	0.00117	CcSEcCtD
Lovastatin—Decreased appetite—Dexamethasone—multiple sclerosis	0.00018	0.00117	CcSEcCtD
Lovastatin—Nausea—Mitoxantrone—multiple sclerosis	0.00018	0.00117	CcSEcCtD
Lovastatin—Infection—Prednisone—multiple sclerosis	0.000179	0.00116	CcSEcCtD
Lovastatin—Back pain—Methotrexate—multiple sclerosis	0.000178	0.00116	CcSEcCtD
Lovastatin—Fatigue—Dexamethasone—multiple sclerosis	0.000178	0.00116	CcSEcCtD
Lovastatin—Fatigue—Betamethasone—multiple sclerosis	0.000178	0.00116	CcSEcCtD
Lovastatin—Pain—Dexamethasone—multiple sclerosis	0.000177	0.00115	CcSEcCtD
Lovastatin—Pain—Betamethasone—multiple sclerosis	0.000177	0.00115	CcSEcCtD
Lovastatin—Vision blurred—Methotrexate—multiple sclerosis	0.000174	0.00113	CcSEcCtD
Lovastatin—Anorexia—Prednisone—multiple sclerosis	0.000172	0.00112	CcSEcCtD
Lovastatin—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000171	0.00111	CcSEcCtD
Lovastatin—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00017	0.00111	CcSEcCtD
Lovastatin—Feeling abnormal—Betamethasone—multiple sclerosis	0.00017	0.00111	CcSEcCtD
Lovastatin—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000169	0.0011	CcSEcCtD
Lovastatin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000169	0.0011	CcSEcCtD
Lovastatin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000168	0.00109	CcSEcCtD
Lovastatin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000168	0.00109	CcSEcCtD
Lovastatin—Malaise—Methotrexate—multiple sclerosis	0.000166	0.00108	CcSEcCtD
Lovastatin—CYP2C8—brain—multiple sclerosis	0.000166	0.00887	CbGeAlD
Lovastatin—Vertigo—Methotrexate—multiple sclerosis	0.000166	0.00108	CcSEcCtD
Lovastatin—Leukopenia—Methotrexate—multiple sclerosis	0.000165	0.00107	CcSEcCtD
Lovastatin—Urticaria—Betamethasone—multiple sclerosis	0.000164	0.00107	CcSEcCtD
Lovastatin—Urticaria—Dexamethasone—multiple sclerosis	0.000164	0.00107	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000164	0.00107	CcSEcCtD
Lovastatin—Dizziness—Prednisolone—multiple sclerosis	0.000164	0.00107	CcSEcCtD
Lovastatin—Asthenia—Triamcinolone—multiple sclerosis	0.000164	0.00106	CcSEcCtD
Lovastatin—Body temperature increased—Dexamethasone—multiple sclerosis	0.000164	0.00106	CcSEcCtD
Lovastatin—Abdominal pain—Dexamethasone—multiple sclerosis	0.000164	0.00106	CcSEcCtD
Lovastatin—Abdominal pain—Betamethasone—multiple sclerosis	0.000164	0.00106	CcSEcCtD
Lovastatin—Body temperature increased—Betamethasone—multiple sclerosis	0.000164	0.00106	CcSEcCtD
Lovastatin—Asthenia—Methylprednisolone—multiple sclerosis	0.000163	0.00106	CcSEcCtD
Lovastatin—Insomnia—Prednisone—multiple sclerosis	0.000163	0.00106	CcSEcCtD
Lovastatin—Paraesthesia—Prednisone—multiple sclerosis	0.000162	0.00105	CcSEcCtD
Lovastatin—Pruritus—Triamcinolone—multiple sclerosis	0.000161	0.00105	CcSEcCtD
Lovastatin—Pruritus—Methylprednisolone—multiple sclerosis	0.000161	0.00105	CcSEcCtD
Lovastatin—Dyspepsia—Prednisone—multiple sclerosis	0.000159	0.00103	CcSEcCtD
Lovastatin—Myalgia—Methotrexate—multiple sclerosis	0.000157	0.00102	CcSEcCtD
Lovastatin—Chest pain—Methotrexate—multiple sclerosis	0.000157	0.00102	CcSEcCtD
Lovastatin—Arthralgia—Methotrexate—multiple sclerosis	0.000157	0.00102	CcSEcCtD
Lovastatin—Decreased appetite—Prednisone—multiple sclerosis	0.000157	0.00102	CcSEcCtD
Lovastatin—Rash—Prednisolone—multiple sclerosis	0.000156	0.00102	CcSEcCtD
Lovastatin—Dermatitis—Prednisolone—multiple sclerosis	0.000156	0.00101	CcSEcCtD
Lovastatin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000156	0.00101	CcSEcCtD
Lovastatin—Fatigue—Prednisone—multiple sclerosis	0.000155	0.00101	CcSEcCtD
Lovastatin—Headache—Prednisolone—multiple sclerosis	0.000155	0.00101	CcSEcCtD
Lovastatin—Discomfort—Methotrexate—multiple sclerosis	0.000155	0.00101	CcSEcCtD
Lovastatin—Constipation—Prednisone—multiple sclerosis	0.000154	0.001	CcSEcCtD
Lovastatin—Confusional state—Methotrexate—multiple sclerosis	0.000152	0.000986	CcSEcCtD
Lovastatin—Dizziness—Triamcinolone—multiple sclerosis	0.000151	0.000979	CcSEcCtD
Lovastatin—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000151	0.000978	CcSEcCtD
Lovastatin—Dizziness—Methylprednisolone—multiple sclerosis	0.00015	0.000977	CcSEcCtD
Lovastatin—Infection—Methotrexate—multiple sclerosis	0.00015	0.000972	CcSEcCtD
Lovastatin—Feeling abnormal—Prednisone—multiple sclerosis	0.000148	0.000964	CcSEcCtD
Lovastatin—Asthenia—Dexamethasone—multiple sclerosis	0.000148	0.000964	CcSEcCtD
Lovastatin—Asthenia—Betamethasone—multiple sclerosis	0.000148	0.000964	CcSEcCtD
Lovastatin—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000147	0.000958	CcSEcCtD
Lovastatin—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000147	0.000957	CcSEcCtD
Lovastatin—Nausea—Prednisolone—multiple sclerosis	0.000147	0.000957	CcSEcCtD
Lovastatin—CYP3A4—nervous system—multiple sclerosis	0.000147	0.00786	CbGeAlD
Lovastatin—Pruritus—Dexamethasone—multiple sclerosis	0.000146	0.000951	CcSEcCtD
Lovastatin—Pruritus—Betamethasone—multiple sclerosis	0.000146	0.000951	CcSEcCtD
Lovastatin—Vomiting—Triamcinolone—multiple sclerosis	0.000145	0.000942	CcSEcCtD
Lovastatin—CYP2D6—nervous system—multiple sclerosis	0.000145	0.00773	CbGeAlD
Lovastatin—Vomiting—Methylprednisolone—multiple sclerosis	0.000145	0.00094	CcSEcCtD
Lovastatin—Rash—Triamcinolone—multiple sclerosis	0.000144	0.000934	CcSEcCtD
Lovastatin—Dermatitis—Triamcinolone—multiple sclerosis	0.000144	0.000933	CcSEcCtD
Lovastatin—Anorexia—Methotrexate—multiple sclerosis	0.000144	0.000932	CcSEcCtD
Lovastatin—Rash—Methylprednisolone—multiple sclerosis	0.000143	0.000932	CcSEcCtD
Lovastatin—Dermatitis—Methylprednisolone—multiple sclerosis	0.000143	0.000931	CcSEcCtD
Lovastatin—Urticaria—Prednisone—multiple sclerosis	0.000143	0.00093	CcSEcCtD
Lovastatin—Headache—Triamcinolone—multiple sclerosis	0.000143	0.000928	CcSEcCtD
Lovastatin—Headache—Methylprednisolone—multiple sclerosis	0.000143	0.000926	CcSEcCtD
Lovastatin—Abdominal pain—Prednisone—multiple sclerosis	0.000142	0.000925	CcSEcCtD
Lovastatin—Body temperature increased—Prednisone—multiple sclerosis	0.000142	0.000925	CcSEcCtD
Lovastatin—CYP3A4—central nervous system—multiple sclerosis	0.000142	0.00756	CbGeAlD
Lovastatin—Diarrhoea—Dexamethasone—multiple sclerosis	0.000142	0.00092	CcSEcCtD
Lovastatin—Diarrhoea—Betamethasone—multiple sclerosis	0.000142	0.00092	CcSEcCtD
Lovastatin—CYP2D6—central nervous system—multiple sclerosis	0.000139	0.00744	CbGeAlD
Lovastatin—ABCB1—medulla oblongata—multiple sclerosis	0.000139	0.0074	CbGeAlD
Lovastatin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000137	0.000891	CcSEcCtD
Lovastatin—Dizziness—Betamethasone—multiple sclerosis	0.000137	0.000889	CcSEcCtD
Lovastatin—Dizziness—Dexamethasone—multiple sclerosis	0.000137	0.000889	CcSEcCtD
Lovastatin—CYP2D6—cerebellum—multiple sclerosis	0.000136	0.00728	CbGeAlD
Lovastatin—Insomnia—Methotrexate—multiple sclerosis	0.000136	0.000885	CcSEcCtD
Lovastatin—Nausea—Triamcinolone—multiple sclerosis	0.000135	0.00088	CcSEcCtD
Lovastatin—Paraesthesia—Methotrexate—multiple sclerosis	0.000135	0.000878	CcSEcCtD
Lovastatin—Nausea—Methylprednisolone—multiple sclerosis	0.000135	0.000878	CcSEcCtD
Lovastatin—Dyspnoea—Methotrexate—multiple sclerosis	0.000134	0.000872	CcSEcCtD
Lovastatin—Hypersensitivity—Prednisone—multiple sclerosis	0.000133	0.000862	CcSEcCtD
Lovastatin—Dyspepsia—Methotrexate—multiple sclerosis	0.000133	0.000861	CcSEcCtD
Lovastatin—Vomiting—Dexamethasone—multiple sclerosis	0.000132	0.000854	CcSEcCtD
Lovastatin—Vomiting—Betamethasone—multiple sclerosis	0.000132	0.000854	CcSEcCtD
Lovastatin—Decreased appetite—Methotrexate—multiple sclerosis	0.000131	0.00085	CcSEcCtD
Lovastatin—Rash—Betamethasone—multiple sclerosis	0.00013	0.000847	CcSEcCtD
Lovastatin—Rash—Dexamethasone—multiple sclerosis	0.00013	0.000847	CcSEcCtD
Lovastatin—Dermatitis—Betamethasone—multiple sclerosis	0.00013	0.000847	CcSEcCtD
Lovastatin—Dermatitis—Dexamethasone—multiple sclerosis	0.00013	0.000847	CcSEcCtD
Lovastatin—Fatigue—Methotrexate—multiple sclerosis	0.00013	0.000843	CcSEcCtD
Lovastatin—Headache—Betamethasone—multiple sclerosis	0.00013	0.000842	CcSEcCtD
Lovastatin—Headache—Dexamethasone—multiple sclerosis	0.00013	0.000842	CcSEcCtD
Lovastatin—Asthenia—Prednisone—multiple sclerosis	0.000129	0.00084	CcSEcCtD
Lovastatin—Pain—Methotrexate—multiple sclerosis	0.000129	0.000836	CcSEcCtD
Lovastatin—Pruritus—Prednisone—multiple sclerosis	0.000127	0.000828	CcSEcCtD
Lovastatin—ABCB1—midbrain—multiple sclerosis	0.000127	0.00676	CbGeAlD
Lovastatin—Feeling abnormal—Methotrexate—multiple sclerosis	0.000124	0.000806	CcSEcCtD
Lovastatin—ABCB1—spinal cord—multiple sclerosis	0.000124	0.0066	CbGeAlD
Lovastatin—Diarrhoea—Prednisone—multiple sclerosis	0.000123	0.000801	CcSEcCtD
Lovastatin—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000123	0.0008	CcSEcCtD
Lovastatin—Nausea—Betamethasone—multiple sclerosis	0.000123	0.000798	CcSEcCtD
Lovastatin—Nausea—Dexamethasone—multiple sclerosis	0.000123	0.000798	CcSEcCtD
Lovastatin—Urticaria—Methotrexate—multiple sclerosis	0.00012	0.000777	CcSEcCtD
Lovastatin—Dizziness—Prednisone—multiple sclerosis	0.000119	0.000774	CcSEcCtD
Lovastatin—Abdominal pain—Methotrexate—multiple sclerosis	0.000119	0.000773	CcSEcCtD
Lovastatin—Body temperature increased—Methotrexate—multiple sclerosis	0.000119	0.000773	CcSEcCtD
Lovastatin—Vomiting—Prednisone—multiple sclerosis	0.000115	0.000744	CcSEcCtD
Lovastatin—Rash—Prednisone—multiple sclerosis	0.000114	0.000738	CcSEcCtD
Lovastatin—Dermatitis—Prednisone—multiple sclerosis	0.000113	0.000737	CcSEcCtD
Lovastatin—Headache—Prednisone—multiple sclerosis	0.000113	0.000733	CcSEcCtD
Lovastatin—Hypersensitivity—Methotrexate—multiple sclerosis	0.000111	0.000721	CcSEcCtD
Lovastatin—CYP2D6—brain—multiple sclerosis	0.000111	0.00591	CbGeAlD
Lovastatin—Asthenia—Methotrexate—multiple sclerosis	0.000108	0.000702	CcSEcCtD
Lovastatin—Nausea—Prednisone—multiple sclerosis	0.000107	0.000695	CcSEcCtD
Lovastatin—Pruritus—Methotrexate—multiple sclerosis	0.000107	0.000692	CcSEcCtD
Lovastatin—ABCB1—nervous system—multiple sclerosis	0.000104	0.00556	CbGeAlD
Lovastatin—Diarrhoea—Methotrexate—multiple sclerosis	0.000103	0.000669	CcSEcCtD
Lovastatin—ABCB1—central nervous system—multiple sclerosis	0.0001	0.00535	CbGeAlD
Lovastatin—Dizziness—Methotrexate—multiple sclerosis	9.96e-05	0.000647	CcSEcCtD
Lovastatin—ABCB1—cerebellum—multiple sclerosis	9.8e-05	0.00523	CbGeAlD
Lovastatin—Vomiting—Methotrexate—multiple sclerosis	9.57e-05	0.000622	CcSEcCtD
Lovastatin—Rash—Methotrexate—multiple sclerosis	9.49e-05	0.000617	CcSEcCtD
Lovastatin—Dermatitis—Methotrexate—multiple sclerosis	9.49e-05	0.000616	CcSEcCtD
Lovastatin—Headache—Methotrexate—multiple sclerosis	9.43e-05	0.000613	CcSEcCtD
Lovastatin—Nausea—Methotrexate—multiple sclerosis	8.94e-05	0.000581	CcSEcCtD
Lovastatin—ABCB1—brain—multiple sclerosis	7.96e-05	0.00425	CbGeAlD
Lovastatin—HDAC2—Gene Expression—PABPC1—multiple sclerosis	6.33e-05	0.000401	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—SRM—multiple sclerosis	6.27e-05	0.000397	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—TYK2—multiple sclerosis	6.27e-05	0.000397	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.24e-05	0.000395	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—CD80—multiple sclerosis	6.22e-05	0.000394	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.22e-05	0.000394	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.22e-05	0.000394	CbGpPWpGaD
Lovastatin—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.12e-05	0.000387	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GPC5—multiple sclerosis	5.92e-05	0.000375	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IFNG—multiple sclerosis	5.88e-05	0.000372	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—S1PR1—multiple sclerosis	5.87e-05	0.000371	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.86e-05	0.000371	CbGpPWpGaD
Lovastatin—CYP3A7—Biological oxidations—POMC—multiple sclerosis	5.82e-05	0.000368	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—TYK2—multiple sclerosis	5.81e-05	0.000368	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—RRM1—multiple sclerosis	5.77e-05	0.000365	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—RPL5—multiple sclerosis	5.71e-05	0.000361	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—GPC5—multiple sclerosis	5.71e-05	0.000361	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CD4—multiple sclerosis	5.67e-05	0.000359	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—CYP27B1—multiple sclerosis	5.63e-05	0.000357	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—CYP24A1—multiple sclerosis	5.63e-05	0.000357	CbGpPWpGaD
Lovastatin—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.63e-05	0.000356	CbGpPWpGaD
Lovastatin—UGT2B7—NRF2 pathway—TGFB1—multiple sclerosis	5.59e-05	0.000354	CbGpPWpGaD
Lovastatin—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.58e-05	0.000353	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.55e-05	0.000351	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.55e-05	0.000351	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.54e-05	0.000351	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.51e-05	0.000349	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.49e-05	0.000347	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	5.38e-05	0.000341	CbGpPWpGaD
Lovastatin—HDAC2—Disease—RPL5—multiple sclerosis	5.3e-05	0.000335	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CYP27B1—multiple sclerosis	5.26e-05	0.000333	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CYP24A1—multiple sclerosis	5.26e-05	0.000333	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL1B—multiple sclerosis	5.24e-05	0.000332	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL2—multiple sclerosis	5.22e-05	0.000331	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—IL2RA—multiple sclerosis	5.22e-05	0.000331	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GPC5—multiple sclerosis	5.15e-05	0.000326	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SLC11A1—multiple sclerosis	5.07e-05	0.000321	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.06e-05	0.00032	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.06e-05	0.00032	CbGpPWpGaD
Lovastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	5.01e-05	0.000317	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—RGS1—multiple sclerosis	4.99e-05	0.000316	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	4.92e-05	0.000311	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—RRM1—multiple sclerosis	4.9e-05	0.00031	CbGpPWpGaD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.85e-05	0.000307	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CYP27B1—multiple sclerosis	4.82e-05	0.000305	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CYP24A1—multiple sclerosis	4.82e-05	0.000305	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GPC5—multiple sclerosis	4.81e-05	0.000304	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—GPR65—multiple sclerosis	4.73e-05	0.000299	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.71e-05	0.000299	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.71e-05	0.000298	CbGpPWpGaD
Lovastatin—UGT1A1—NRF2 pathway—TGFB1—multiple sclerosis	4.55e-05	0.000288	CbGpPWpGaD
Lovastatin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.54e-05	0.000287	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—SRM—multiple sclerosis	4.54e-05	0.000287	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—PGR—multiple sclerosis	4.49e-05	0.000284	CbGpPWpGaD
Lovastatin—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	4.44e-05	0.000281	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	4.42e-05	0.00028	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	4.42e-05	0.00028	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GPC5—multiple sclerosis	4.41e-05	0.000279	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—STAT3—multiple sclerosis	4.39e-05	0.000278	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	4.39e-05	0.000278	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL2—multiple sclerosis	4.37e-05	0.000277	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCR1—multiple sclerosis	4.32e-05	0.000274	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CXCL13—multiple sclerosis	4.32e-05	0.000274	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	4.32e-05	0.000274	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.3e-05	0.000272	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—RRM1—multiple sclerosis	4.27e-05	0.00027	CbGpPWpGaD
Lovastatin—CYP3A5—Biological oxidations—POMC—multiple sclerosis	4.2e-05	0.000266	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.2e-05	0.000266	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.15e-05	0.000263	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—STAT3—multiple sclerosis	4.06e-05	0.000257	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—BCHE—multiple sclerosis	4.06e-05	0.000257	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CD28—multiple sclerosis	4.05e-05	0.000257	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GPC5—multiple sclerosis	4.04e-05	0.000256	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—MAPK1—multiple sclerosis	3.99e-05	0.000253	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—RRM1—multiple sclerosis	3.98e-05	0.000252	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—SRM—multiple sclerosis	3.93e-05	0.000249	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—ALB—multiple sclerosis	3.77e-05	0.000239	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—IL6—multiple sclerosis	3.76e-05	0.000238	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	3.7e-05	0.000234	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—MAPK1—multiple sclerosis	3.7e-05	0.000234	CbGpPWpGaD
Lovastatin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.68e-05	0.000233	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—RRM1—multiple sclerosis	3.65e-05	0.000231	CbGpPWpGaD
Lovastatin—CYP2C8—Biological oxidations—POMC—multiple sclerosis	3.64e-05	0.000231	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—SRM—multiple sclerosis	3.51e-05	0.000222	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—SRM—multiple sclerosis	3.42e-05	0.000217	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	3.41e-05	0.000216	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—RRM1—multiple sclerosis	3.35e-05	0.000212	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.32e-05	0.00021	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.31e-05	0.00021	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—BCHE—multiple sclerosis	3.31e-05	0.00021	CbGpPWpGaD
Lovastatin—CYP2C19—Biological oxidations—POMC—multiple sclerosis	3.25e-05	0.000206	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SRM—multiple sclerosis	3.23e-05	0.000204	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SRM—multiple sclerosis	3.2e-05	0.000202	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	3.2e-05	0.000202	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	3.2e-05	0.000202	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—TNF—multiple sclerosis	3.18e-05	0.000202	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—VDR—multiple sclerosis	3.14e-05	0.000199	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCL3—multiple sclerosis	3.08e-05	0.000195	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL6—multiple sclerosis	3.07e-05	0.000194	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—IL2—multiple sclerosis	3.06e-05	0.000194	CbGpPWpGaD
Lovastatin—CYP2D6—Biological oxidations—POMC—multiple sclerosis	2.99e-05	0.000189	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PTGER4—multiple sclerosis	2.97e-05	0.000188	CbGpPWpGaD
Lovastatin—CYP2C9—Biological oxidations—POMC—multiple sclerosis	2.96e-05	0.000188	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.93e-05	0.000186	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GPC5—multiple sclerosis	2.92e-05	0.000185	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PGR—multiple sclerosis	2.92e-05	0.000185	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CD86—multiple sclerosis	2.89e-05	0.000183	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CXCR3—multiple sclerosis	2.86e-05	0.000181	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.85e-05	0.00018	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—IL6—multiple sclerosis	2.84e-05	0.00018	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CD28—multiple sclerosis	2.84e-05	0.00018	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.83e-05	0.000179	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—BCHE—multiple sclerosis	2.82e-05	0.000178	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCR2—multiple sclerosis	2.79e-05	0.000176	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	2.77e-05	0.000175	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	2.77e-05	0.000175	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.71e-05	0.000171	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.59e-05	0.000164	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CNR1—multiple sclerosis	2.57e-05	0.000163	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CCR5—multiple sclerosis	2.56e-05	0.000162	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GPC5—multiple sclerosis	2.53e-05	0.00016	CbGpPWpGaD
Lovastatin—HDAC2—Disease—HLA-A—multiple sclerosis	2.5e-05	0.000158	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.47e-05	0.000156	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.47e-05	0.000156	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.47e-05	0.000156	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—BCHE—multiple sclerosis	2.45e-05	0.000155	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—APOE—multiple sclerosis	2.44e-05	0.000155	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.43e-05	0.000154	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—RRM1—multiple sclerosis	2.42e-05	0.000153	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.41e-05	0.000153	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.41e-05	0.000153	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.41e-05	0.000153	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—TGFB1—multiple sclerosis	2.39e-05	0.000151	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—MAPK1—multiple sclerosis	2.34e-05	0.000148	CbGpPWpGaD
Lovastatin—HDAC2—Disease—APOE—multiple sclerosis	2.33e-05	0.000148	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CXCL10—multiple sclerosis	2.32e-05	0.000147	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—BCHE—multiple sclerosis	2.29e-05	0.000145	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	2.27e-05	0.000144	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	2.27e-05	0.000144	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.26e-05	0.000143	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.25e-05	0.000143	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.25e-05	0.000143	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.25e-05	0.000142	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.22e-05	0.00014	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GPC5—multiple sclerosis	2.21e-05	0.00014	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.2e-05	0.000139	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.11e-05	0.000134	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CD80—multiple sclerosis	2.11e-05	0.000134	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SRM—multiple sclerosis	2.11e-05	0.000134	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—POMC—multiple sclerosis	2.1e-05	0.000133	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—RRM1—multiple sclerosis	2.1e-05	0.000133	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—BCHE—multiple sclerosis	2.1e-05	0.000133	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.08e-05	0.000132	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.06e-05	0.00013	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CD86—multiple sclerosis	2.02e-05	0.000128	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCL5—multiple sclerosis	1.99e-05	0.000126	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—APOE—multiple sclerosis	1.99e-05	0.000126	CbGpPWpGaD
Lovastatin—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.95e-05	0.000124	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—BCHE—multiple sclerosis	1.92e-05	0.000122	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—ALB—multiple sclerosis	1.91e-05	0.000121	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.87e-05	0.000119	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SPP1—multiple sclerosis	1.85e-05	0.000117	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—RRM1—multiple sclerosis	1.83e-05	0.000116	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCR5—multiple sclerosis	1.8e-05	0.000114	CbGpPWpGaD
Lovastatin—HDAC2—Disease—TYK2—multiple sclerosis	1.78e-05	0.000113	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL2RA—multiple sclerosis	1.77e-05	0.000112	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.72e-05	0.000109	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—POMC—multiple sclerosis	1.71e-05	0.000108	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.71e-05	0.000108	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—APOE—multiple sclerosis	1.69e-05	0.000107	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.69e-05	0.000107	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.68e-05	0.000107	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.65e-05	0.000104	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—APOE—multiple sclerosis	1.63e-05	0.000103	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.63e-05	0.000103	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CD4—multiple sclerosis	1.61e-05	0.000102	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.57e-05	9.95e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—ALB—multiple sclerosis	1.56e-05	9.88e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.49e-05	9.41e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.49e-05	9.41e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CD80—multiple sclerosis	1.48e-05	9.35e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—APOE—multiple sclerosis	1.48e-05	9.34e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—POMC—multiple sclerosis	1.46e-05	9.21e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.45e-05	9.2e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—POMC—multiple sclerosis	1.4e-05	8.89e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.4e-05	8.85e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.39e-05	8.81e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—APOE—multiple sclerosis	1.38e-05	8.72e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCL2—multiple sclerosis	1.37e-05	8.69e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.36e-05	8.6e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—ALB—multiple sclerosis	1.33e-05	8.4e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.32e-05	8.39e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.27e-05	8.07e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—POMC—multiple sclerosis	1.27e-05	8.02e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—APOE—multiple sclerosis	1.26e-05	7.99e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.25e-05	7.9e-05	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—MYC—multiple sclerosis	1.25e-05	7.9e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TYK2—multiple sclerosis	1.25e-05	7.9e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—STAT3—multiple sclerosis	1.25e-05	7.89e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.2e-05	7.63e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—POMC—multiple sclerosis	1.18e-05	7.49e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MYC—multiple sclerosis	1.16e-05	7.34e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—APOE—multiple sclerosis	1.16e-05	7.33e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—TGFB1—multiple sclerosis	1.16e-05	7.32e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ALB—multiple sclerosis	1.16e-05	7.32e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.14e-05	7.21e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.14e-05	7.2e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MAPK1—multiple sclerosis	1.13e-05	7.18e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.13e-05	7.13e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—POMC—multiple sclerosis	1.08e-05	6.86e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ALB—multiple sclerosis	1.08e-05	6.83e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.08e-05	6.81e-05	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.06e-05	6.69e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—BCHE—multiple sclerosis	1.05e-05	6.65e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL2—multiple sclerosis	1.04e-05	6.57e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.04e-05	6.57e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—POMC—multiple sclerosis	9.95e-06	6.3e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—BCHE—multiple sclerosis	9.89e-06	6.26e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ALB—multiple sclerosis	9.88e-06	6.26e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MMP9—multiple sclerosis	9.82e-06	6.22e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—BCHE—multiple sclerosis	9.81e-06	6.21e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ALB—multiple sclerosis	9.07e-06	5.74e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—STAT3—multiple sclerosis	8.73e-06	5.53e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—IL6—multiple sclerosis	8.71e-06	5.51e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—APOE—multiple sclerosis	8.37e-06	5.3e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MYC—multiple sclerosis	8.11e-06	5.14e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TGFB1—multiple sclerosis	8.09e-06	5.12e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MAPK1—multiple sclerosis	7.94e-06	5.03e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—APOE—multiple sclerosis	7.25e-06	4.59e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—POMC—multiple sclerosis	7.19e-06	4.55e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ALB—multiple sclerosis	6.55e-06	4.15e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—APOE—multiple sclerosis	6.47e-06	4.1e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—BCHE—multiple sclerosis	6.47e-06	4.1e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—APOE—multiple sclerosis	6.31e-06	4e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—POMC—multiple sclerosis	6.23e-06	3.94e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL6—multiple sclerosis	6.1e-06	3.86e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—APOE—multiple sclerosis	5.95e-06	3.77e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—APOE—multiple sclerosis	5.9e-06	3.74e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ALB—multiple sclerosis	5.68e-06	3.59e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—POMC—multiple sclerosis	5.56e-06	3.52e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—POMC—multiple sclerosis	5.42e-06	3.43e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—POMC—multiple sclerosis	5.11e-06	3.24e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—POMC—multiple sclerosis	5.07e-06	3.21e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ALB—multiple sclerosis	5.07e-06	3.21e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ALB—multiple sclerosis	4.95e-06	3.13e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ALB—multiple sclerosis	4.66e-06	2.95e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ALB—multiple sclerosis	4.62e-06	2.93e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—APOE—multiple sclerosis	3.89e-06	2.46e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—POMC—multiple sclerosis	3.34e-06	2.12e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALB—multiple sclerosis	3.05e-06	1.93e-05	CbGpPWpGaD
